220 related articles for article (PubMed ID: 33034777)
1. Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies.
Grings M; Wajner M; Leipnitz G
Cell Mol Neurobiol; 2022 Apr; 42(3):565-575. PubMed ID: 33034777
[TBL] [Abstract][Full Text] [Related]
2. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.
Tiranti V; Viscomi C; Hildebrandt T; Di Meo I; Mineri R; Tiveron C; Levitt MD; Prelle A; Fagiolari G; Rimoldi M; Zeviani M
Nat Med; 2009 Feb; 15(2):200-5. PubMed ID: 19136963
[TBL] [Abstract][Full Text] [Related]
3. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.
Barth M; Ottolenghi C; Hubert L; Chrétien D; Serre V; Gobin S; Romano S; Vassault A; Sefiani A; Ricquier D; Boddaert N; Brivet M; de Keyzer Y; Munnich A; Duran M; Rabier D; Valayannopoulos V; de Lonlay P
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S443-53. PubMed ID: 20978941
[TBL] [Abstract][Full Text] [Related]
4. Improved clinical outcome following liver transplant in patients with ethylmalonic encephalopathy.
Tam A; AlDhaheri NS; Mysore K; Tessier ME; Goss J; Fernandez LA; D'Alessandro AM; Schwoerer JS; Rice GM; Elsea SH; Scaglia F
Am J Med Genet A; 2019 Jun; 179(6):1015-1019. PubMed ID: 30864297
[TBL] [Abstract][Full Text] [Related]
5. Ethylmalonic encephalopathy ETHE1 R163W/R163Q mutations alter protein stability and redox properties of the iron centre.
Henriques BJ; Lucas TG; Rodrigues JV; Frederiksen JH; Teixeira MS; Tiranti V; Bross P; Gomes CM
PLoS One; 2014; 9(9):e107157. PubMed ID: 25198162
[TBL] [Abstract][Full Text] [Related]
6. Severe early onset ethylmalonic encephalopathy with West syndrome.
Papetti L; Garone G; Schettini L; Giordano C; Nicita F; Papoff P; Zeviani M; Leuzzi V; Spalice A
Metab Brain Dis; 2015 Dec; 30(6):1537-45. PubMed ID: 26194623
[TBL] [Abstract][Full Text] [Related]
7. Bioenergetics dysfunction, mitochondrial permeability transition pore opening and lipid peroxidation induced by hydrogen sulfide as relevant pathomechanisms underlying the neurological dysfunction characteristic of ethylmalonic encephalopathy.
Cardoso GMF; Pletsch JT; Parmeggiani B; Grings M; Glanzel NM; Bobermin LD; Amaral AU; Wajner M; Leipnitz G
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2192-2201. PubMed ID: 28624490
[TBL] [Abstract][Full Text] [Related]
8. An atypically mild case of ethylmalonic encephalopathy with pathogenic ETHE1 variant.
Kashima DT; Sloan-Heggen CM; Gottlieb-Smith RJ; Barone Pritchard A
Am J Med Genet A; 2023 Jun; 191(6):1614-1618. PubMed ID: 36891747
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel homozygous nonsense variant in a Chinese patient with ethylmalonic encephalopathy and a genotype-phenotype spectrum review.
Tao Y; Han D; Li X; Wang L; Yue L; Huang C; Lu D; Li X
Clin Chim Acta; 2020 Oct; 509():8-17. PubMed ID: 32485156
[TBL] [Abstract][Full Text] [Related]
10. Ethylmalonic Encephalopathy in an Indian Boy.
Bijarnia-Mahay S; Gupta D; Shigematsu Y; Yamaguchi S; Saxena R; Verma IC
Indian Pediatr; 2016 Oct; 53(10):914-916. PubMed ID: 27771676
[TBL] [Abstract][Full Text] [Related]
11. ETHE1 mutations are specific to ethylmalonic encephalopathy.
Tiranti V; Briem E; Lamantea E; Mineri R; Papaleo E; De Gioia L; Forlani F; Rinaldo P; Dickson P; Abu-Libdeh B; Cindro-Heberle L; Owaidha M; Jack RM; Christensen E; Burlina A; Zeviani M
J Med Genet; 2006 Apr; 43(4):340-6. PubMed ID: 16183799
[TBL] [Abstract][Full Text] [Related]
12. Ethylmalonic encephalopathy masquerading as meningococcemia.
Horton A; Hong KM; Pandithan D; Allen M; Killick C; Goergen S; Springer A; Phelan D; Marty M; Halligan R; Lee J; Pitt J; Chong B; Christodoulou J; Lunke S; Stark Z; Fahey M
Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35165146
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the mitochondrial sulfide regulator ETHE1 disturbs cell growth, glutathione level and causes proteome alterations outside mitochondria.
Sahebekhtiari N; Fernandez-Guerra P; Nochi Z; Carlsen J; Bross P; Palmfeldt J
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):126-135. PubMed ID: 30391543
[TBL] [Abstract][Full Text] [Related]
14. Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy.
Boyer M; Sowa M; Di Meo I; Eftekharian S; Steenari MR; Tiranti V; Abdenur JE
Mol Genet Metab; 2018 May; 124(1):57-63. PubMed ID: 29526615
[TBL] [Abstract][Full Text] [Related]
15. Compromised therapeutic value of pediatric liver transplantation in ethylmalonic encephalopathy: A case report.
Zhou GP; Qu W; Zhu ZJ; Sun LY; Wei L; Zeng ZG; Liu Y
World J Gastroenterol; 2020 Oct; 26(40):6295-6303. PubMed ID: 33177801
[TBL] [Abstract][Full Text] [Related]
16. Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy.
Giordano C; Viscomi C; Orlandi M; Papoff P; Spalice A; Burlina A; Di Meo I; Tiranti V; Leuzzi V; d'Amati G; Zeviani M
J Inherit Metab Dis; 2012 May; 35(3):451-8. PubMed ID: 22020834
[TBL] [Abstract][Full Text] [Related]
17. Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.
Kabil O; Banerjee R
J Biol Chem; 2012 Dec; 287(53):44561-7. PubMed ID: 23144459
[TBL] [Abstract][Full Text] [Related]
18. Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease.
Dionisi-Vici C; Diodato D; Torre G; Picca S; Pariante R; Giuseppe Picardo S; Di Meo I; Rizzo C; Tiranti V; Zeviani M; De Ville De Goyet J
Brain; 2016 Apr; 139(Pt 4):1045-51. PubMed ID: 26917598
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.
Pettinati I; Brem J; McDonough MA; Schofield CJ
Hum Mol Genet; 2015 May; 24(9):2458-69. PubMed ID: 25596185
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.
Kılıç M; Dedeoğlu Ö; Göçmen R; Kesici S; Yüksel D
Metab Brain Dis; 2017 Apr; 32(2):293-296. PubMed ID: 27830356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
